Electrochemotherapy of unresectable cutaneous tumors  with reduced dosages of intravenous bleomycin: analysis of 57 patients from the InspECT (International network for sharing practices of ElectroChemoTherapy) registry

ConclusionsECT performed with reduced bleomycin dosages could be as effective as with currently recommended dose. Patients with impaired renal function or candidate to multiple ECT cycles could benefit from a reduced dose protocol. Our findings need prospective confirmation before being adopted in clinical practice.This article is protected by copyright. All rights reserved.

Source: Journal of the European Academy of Dermatology and Venereology - November 24, 2017 Category: Dermatology Authors: R. Rotunno, L. G. Campana, P. Quaglino, F. de Terlizzi, C. Kunte, J. Odili, J. Gehl, S. Ribero, S H. Liew, R. Marconato, M. Brizio, P. Curatolo Tags: Original Article Source Type: research